- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06301581
Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
This is a retrospective study designed to collect speech perception results for HiRes Ultra CI and HiRes Ultra 3D CI users as measured in the clinical routine and to confirm the performance of these devices.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kliesch Sven
- Phone Number: 49 511 532 8069
- Email: Kliesch.Sven@mh-hannover.de
Study Contact Backup
- Name: Andreas Büchner, Prof
- Phone Number: 49 511 532 8589
- Email: buechner.andreas@mh-hannover.de
Study Locations
-
-
-
Hanover, Germany, D-30625
- Recruiting
- Medizinische Hochschule Hannover
-
Contact:
- Andreas Büchner
-
Principal Investigator:
- Andreas Büchner
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The studied population consists of all CI users implanted with a HiRes Ultra Version V2 or HiRes Ultra 3D Version V2 CI at the Medical University of Hannover in Germany (MHH).
Description
Inclusion Criteria:
-
Unilateral or bilateral HiRes Ultra CI or HiRes Ultra 3D CI users including
- Ultra Version V2 newly implanted on this side (Group 1)
- Ultra Version V2 users implanted following an Ultra Version V1 device failure in the same ear (Group 2)
-
Informed consent signed
Exclusion Criteria:
- no exclusion criteria
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: RETROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 1
HiRes Ultra or HiRes Ultra 3D Version V2 newly implanted on this side |
|
Group 2
HiRes Ultra or HiRes Ultra 3D Version V2 implanted following an Ultra Version V1 device failure on the same ear |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Freiburger monosyllabic word recognition score in quiet in the implanted ear
Time Frame: 12 months after device activation
|
Score obtained with the Freiburger Monosyllabic word test |
12 months after device activation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andreas Büchner, Hannover Medical School
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABIntl-23-42
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.